Analysis and treatment of infectious diseases among the naval ship crew during prolonged deployment at sea
10.3760/cma.j.issn.1009-6906.2016.02.004
- VernacularTitle:长远航舰艇人员感染性疾病分析及其治疗
- Author:
Linhua QIN
1
;
Wanning TONG
;
Zhiwu ZHENG
;
Jiao LYU
;
Yunxing SHI
;
Guozhong ZHOU
;
Zhulin PAN
Author Information
1. 解放军第四一一医院消化内科, 上海,200081
- Publication Type:Journal Article
- Keywords:
Prolonged voyage;
Naval shipboard personnel;
Infectious disease;
Respiratory infection;
Disease spectrum
- From:
Chinese journal of nautical medicine and hyperbaric medicine
2016;23(2):95-97
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the incidence of infectious diseases among the naval shipboard personnel during prolonged deployment at sea and the therapeutic effects.Methods The constitution ratio of infectious diseases among the ship crew during prolonged deployment at sea was calculated and morbidity rates of various infectious diseases at different stages of deployment were compared,and the therapeutic effects of different antibiotics were carefully evaluated.Results During the whole course of prolonged deployment at sea,the constitution ratio of infectious diseases from high percentage to low percentage was respiratory tract infection(65.61％),gastrointestinal tract infection (32.01％),urinary system infection (1.19％) and paronychia(1.19％).The morbidity of gastrointestinal tract infection during the middle stage of deployment was significantly higher than those of the early and late stages.The morbidity of respiratory tract infection during the middle and late stages of deployment was significantly higher than that of the early stage.During the middle and late stages,the cure rate of azithromycin to non-viral respiratory tract infection was significant higher that of cefuroxime.Conclusions Both respiratory tract infection and gastrointestinal tract infection were all commonly seen during prolonged deployment at sea.Significant differences could be noted in the morbidity of respiratory tract infection and respiratory tract infection at different stages of deployment.The therapeutic effect of azithromycin was obviously superior to cefuroxime in the treatment of non-viral respiratory tract infection during the middle and late stages of prolonged deployment at sea.
